Efficacy of Dose-Escalated Chemoradiation on Complete Tumor Response in Patients with Locally Advanced Rectal Cancer (RECTAL-BOOST): A Phase 2 Randomized Controlled Trial
Open Access
- 18 June 2020
- journal article
- research article
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 108 (4), 1008-1018
- https://doi.org/10.1016/j.ijrobp.2020.06.013
Abstract
No abstract availableKeywords
Funding Information
- Maag Lever Darm Stichting (FP 1605)
This publication has 32 references indexed in Scilit:
- Optimal time interval between neoadjuvant chemoradiotherapy and surgery for rectal cancerBritish Journal of Surgery, 2013
- Pre-operative chemoradiation for non-metastatic locally advanced rectal cancerCochrane Database of Systematic Reviews, 2012
- Dose-Effect Relationship in Chemoradiotherapy for Locally Advanced Rectal Cancer: A Randomized Trial Comparing Two Radiation DosesInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation TherapyInternational Journal of Radiation Oncology*Biology*Physics, 2012
- Wait-and-See Policy for Clinical Complete Responders After Chemoradiation for Rectal CancerJournal of Clinical Oncology, 2011
- Diffusion-Weighted MRI for Selection of Complete Responders After Chemoradiation for Locally Advanced Rectal Cancer: A Multicenter StudyAnnals of Surgical Oncology, 2011
- Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" designBMJ, 2010
- Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening TrialsJournal of Clinical Oncology, 2005
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI Journal of the National Cancer Institute, 1993
- LOCAL RECURRENCE OF RECTAL ADENOCARCINOMA DUE TO INADEQUATE SURGICAL RESECTIONThe Lancet, 1986